This reminded me of something I mentioned a few days ago, that initial acne flare.
Whats that about?
Probably some contradictions since this was published.
F. L. Meyskens, Jr., M.D.: The response you see
with isotretinoin is almost like a hormonal response.
We frequently see responses like this in estrogentreated breast cancer, or in response to an antiestrogen
such as tamoxifen. The patients who respond the best
are frequently those who have an initial flare-up suggesting a biphasic response. I wonder whether the effect of retinoids is mediated by an androgen receptor in
the target organ, the sebaceous gland. Is it known
whether the androgen receptor in the skin of individuals
is abnormal?
P. E. Pochi, M.D.: Individuals with severe acne
and high sebum levels have a higher content of androgen receptors in their skin. Whether these are merely a
reflection of greater sebaceous gland size in skin is not
known. But I don’t believe that isotretinoin is antiandrogenic. Did your question imply that?
F. L. Meyskens, .Jr., M.D.: There are two ways to
look at it. One, does tretinoin compete on a competitive
basis with an androgen receptor? Secondly, does isotretinoin function as an antiandrogen, either through an
androgen receptor or through some other receptor,
analogous to estrogen receptor modulation by progesterone in breast cancer? I am just tossing this out as an
idea.
P. E. Pochi, M.D.: It is not very likely. Other
androgen-responsive tissues are unaffected by isotretinoin; there is no reduction of gonadotropins or of
testosterone, and, on the basis of what Dr. Gomez
presented, there does not seem to be a peripheral antiandrogenic effect at the sebaceous gland site.
F. L. Meyskens, Jr., M.D.: But you only get acne
when you are a teenager.
P. E. Poehi, M.D.: Most cases of acne do occur in
the teen years, but some persist or even begin well after
this time.
E. C. Gomez, M.D., Ph.D.: In addition to direct
inhibition of the binding of dihydrotestosterone to the
androgen receptor, the other point of possible antiandrogen action on sebaceous cells is, of course, blockage of the conversion of testosterone to dihydrotestosterone. We have looked at isotretinoin, and it had no
effect on the 5ce-reductase. Inhibition of binding to the
receptor hasn’t been evaluated. As I mentioned, although the molecules are very different, Feldman,
Voigt, and Hsia (J Biol Chem 252:3324, 1977) did
describe an estrogen-binding protein from rat preputial
gland, and tretinoin proved to be a competitive inhibitor for estrogen binding in this system. So there may be
some sort of molecular configuration that allows a retinoid to resemble an estrogen.
P. E. Poehi, M.D.: It doesn’t inhibit 5a-reductase
activity, although it could conceivably inhibit binding,
but then if it did, the pigmentation and the hair growth
of the hamster flank organ would be suppressed, and
Dr. Gomez has shown that they aren’t. The effect on
the sebaceous gland cells is quite selective.
A side note with that,